← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 NewcelX Ltd NCEL $15.1M	–	–	–	–
102	102 DELISTED NKGen Biotech, Inc. Common Stock NKGN	–	–	–	–
103	103 Nkarta NKTX $145M	–	–	–	–
104	104 Intellia Therapeutics NTLA $1.6B	–	–	–	–
105	OBX 105 Obsidian Therapeutics OBX $755M	–	–	–	–
106	106 DELISTED Orgenesis Inc. Common Stock ORGS	–	–	–	–
107	ORTX 107 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	–	–	–	–
108	108 Passage Bio PASG $11.8M	–	–	–	–
109	109 PharmaCyte Biotech PMCB $3.74M	–	–	–	–
110	110 Prime Medicine PRME $568M	–	–	–	–
111	111 ProKidney PROK $307M	–	–	–	–
112	112 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	–	–	–	–
113	RCOR 113 DELISTED Renovacor, Inc. RCOR	–	–	–	–
114	114 Cartesian Therapeutics RNAC $192M	–	–	–	–
115	RUBY 115 DELISTED Rubius Therapeutics, Inc RUBY	–	–	–	–
116	116 Sana Biotechnology SANA $698M	–	–	–	–
117	SCPS 117 DELISTED Scopus BioPharma Inc. Common Stock SCPS	–	–	–	–
118	SCTX 118 Scribe Therapeutics Inc SCTX $393M	–	–	–	–
119	SGTX 119 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
120	SLBT 120 SL Science Holding Ltd SLBT $869M	–	–	–	–
121	121 Solid Biosciences SLDB $585M	–	–	–	–
122	122 Senti Biosciences Holdings SNTI $7.5M	–	–	–	–
123	SQZ 123 DELISTED SQZ Biotechnologies Company SQZ	–	–	–	–
124	TCBP 124 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	–	–	–	–
125	TCRR 125 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	–	–	–	–